logoalt Hacker News

dd8601fntoday at 4:59 PM5 repliesview on HN

I really wish these weren’t forever drugs. I would be next in line.


Replies

arjietoday at 5:22 PM

Interesting. Part of the reason I was eager to use retatrutide was the reversibility. Fantastic drug and entirely reversible. I self-tested and the effects I had on it were reversed entirely in its absence. Similar to caffeine or amphetamine at the doses I have tried (which are not high), removing the intervention resulted in a return to a prior state over a fairly short period. I'd say that, in general, some of the good properties essential to an intervention for a non-debilitating condition are:

* uniform dose-response: easy to increase effect by changing dose

* reversibility: automatic reversion to pre-intervention in a short-term is gold standard - allows for regret escape

* low-cost

GLP-1 drugs have these properties which I like. I'm surprised to hear that someone would prefer the alternative, but I must imagine that cost and the dosing structure (sub-q injection is annoying) must dominate decision making here.

show 1 reply
rayinertoday at 5:56 PM

GLP-1s aren’t “forever drugs.” They’re eliminated so fast from your system you need to keep taking them to keep the effect. That’s the opposite of a forever drug. If you go off them, you just return to the way you were.

show 2 replies
estearumtoday at 5:01 PM

Do you have the same concerns about water or food? Why does it matter that it stops benefitting you if you stop taking it?

show 3 replies
dnauticstoday at 5:03 PM

uniquely among maintenance drugs some people report saving money on GLP-1s, they spend less on food than the drugs cost... But think of the farmers!

Analemma_today at 5:21 PM

Bariatric surgery has most of the same upsides as GLP-1s and is a one-time cost. But I agree with the other commenters that "forever drug" is mostly fretting without an actual reason. The Hunger that engineered foods are deliberately designed to induce is a forever thing too, now there's a counterweapon.

show 1 reply